UHMK1 and pancreatic ductal adenocarcinoma: Similar reports aimed at defining the role of KIS in pancreatic ductal adenocarcinoma (PDAC) have demonstrated that KIS expression is low in non-malignant pancreatic cells and tissues, whereas its expression is significantly increased in several PDAC cell lines and tissues (Luo et al. 2022a).